Inhibition of human immunodeficiency virus type 1 infectivity by a new amine bellenamine
- 31 March 1996
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 29 (2-3) , 163-173
- https://doi.org/10.1016/0166-3542(95)00828-4
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Use of evolutionary limitations of HIV-1 multidrug resistance to optimize therapyNature, 1993
- The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987
- Both 2′,3′-dideoxythymidine and its 2′,3′-unsaturated derivative (2′,3′-dideoxythymidinene) are potent and selective inhibitors of human immunodeficiency virus replication in vitroBiochemical and Biophysical Research Communications, 1987
- Infection of HTLV-III/LAV in HTLV-I-Carrying Cells MT-2 and MT-4 and Application in a Plaque AssayScience, 1985
- T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAVNature, 1984
- The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirusNature, 1984
- Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDSScience, 1984
- Detection, Isolation, and Continuous Production of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and Pre-AIDSScience, 1984
- Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)Science, 1983
- Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cellsNature, 1981